556 related articles for article (PubMed ID: 18167138)
1. Primary hyperparathyroidism and the skeleton.
Mosekilde L
Clin Endocrinol (Oxf); 2008 Jul; 69(1):1-19. PubMed ID: 18167138
[TBL] [Abstract][Full Text] [Related]
2. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.
Christiansen P
APMIS Suppl; 2001; (102):1-52. PubMed ID: 11419022
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism.
Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
Clin Endocrinol (Oxf); 2005 Nov; 63(5):506-13. PubMed ID: 16268801
[TBL] [Abstract][Full Text] [Related]
4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
5. [Primary hyperparathyroidism].
Carnevale V; Romagnoli E; Pipino M; Scillitani A; D'Erasmo E; Minisola S; Mazzuoli G
Clin Ter; 2005; 156(5):211-26. PubMed ID: 16382970
[TBL] [Abstract][Full Text] [Related]
6. Skeletal effects of primary hyperparathyroidism: bone mineral density and fracture risk.
Lewiecki EM; Miller PD
J Clin Densitom; 2013; 16(1):28-32. PubMed ID: 23374738
[TBL] [Abstract][Full Text] [Related]
7. Primary hyperparathyroidism: lessons from bone histomorphometry.
Eriksen EF
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N95-7. PubMed ID: 12412784
[TBL] [Abstract][Full Text] [Related]
8. Asymptomatic primary hyperparathyroidism: surgical and medical management.
Francucci CM; Ceccoli L; Caudarella R; Rilli S; Vescini F; Boscaro M
J Endocrinol Invest; 2011 Jul; 34(7 Suppl):50-4. PubMed ID: 21985981
[TBL] [Abstract][Full Text] [Related]
9. Skeletal actions of intermittent parathyroid hormone: effects on bone remodelling and structure.
Compston JE
Bone; 2007 Jun; 40(6):1447-52. PubMed ID: 17045858
[TBL] [Abstract][Full Text] [Related]
10. Is cortical bone hip? What determines cortical bone properties?
Epstein S
Bone; 2007 Jul; 41(1 Suppl 1):S3-8. PubMed ID: 17466615
[TBL] [Abstract][Full Text] [Related]
11. Calcimimetics versus parathyroidectomy for treatment of primary hyperparathyroidism: retrospective chart analysis of a prospective database.
Keutgen XM; Buitrago D; Filicori F; Kundel A; Elemento O; Fahey TJ; Zarnegar R
Ann Surg; 2012 May; 255(5):981-5. PubMed ID: 22470074
[TBL] [Abstract][Full Text] [Related]
12. Effects of smoking on severity of disease in primary hyperparathyroidism.
Amstrup AK; Rejnmark L; Vestergaard P; Heickendorff L; Mosekilde L
Calcif Tissue Int; 2010 Nov; 87(5):406-13. PubMed ID: 20862465
[TBL] [Abstract][Full Text] [Related]
13. [Bone status after parathyroidectomy for primary hyperparathyroidism].
Yamauchi M; Sugimoto T
Clin Calcium; 2005 Dec; 15(12):11-16. PubMed ID: 16322668
[TBL] [Abstract][Full Text] [Related]
14. Bone metabolism in patients with primary hyperparathyroidism before and after surgery.
Kerschan-Schindl K; Riss P; Krestan C; Rauner M; Bieglmayer C; Gleiss A; Fialka-Moser V; Niederle B; Pietschmann P
Horm Metab Res; 2012 Jun; 44(6):476-81. PubMed ID: 22495973
[TBL] [Abstract][Full Text] [Related]
15. Management of osteoporosis due to ovarian failure.
Eastell R
Med Pediatr Oncol; 2003 Sep; 41(3):222-7. PubMed ID: 12868123
[TBL] [Abstract][Full Text] [Related]
16. Lumbar spine bone mineral density changes in patients with primary hyperparathyroidism according to age and gender.
Lumachi F; Camozzi V; Ermani M; Nardi A; Luisetto G
Ann N Y Acad Sci; 2007 Nov; 1117():362-6. PubMed ID: 17656570
[TBL] [Abstract][Full Text] [Related]
17. Effects of treatment of ovariectomized adult rhesus monkeys with parathyroid hormone 1-84 for 16 months on trabecular and cortical bone structure and biomechanical properties of the proximal femur.
Fox J; Miller MA; Recker RR; Turner CH; Smith SY
Calcif Tissue Int; 2007 Jul; 81(1):53-63. PubMed ID: 17551766
[TBL] [Abstract][Full Text] [Related]
18. Secondary causes of low bone mass in patients with breast cancer: a need for greater vigilance.
Mann GB; Kang YC; Brand C; Ebeling PR; Miller JA
J Clin Oncol; 2009 Aug; 27(22):3605-10. PubMed ID: 19546403
[TBL] [Abstract][Full Text] [Related]
19. Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.
Khan A; Grey A; Shoback D
J Clin Endocrinol Metab; 2009 Feb; 94(2):373-81. PubMed ID: 19193912
[TBL] [Abstract][Full Text] [Related]
20. Primary hyperparathyroidism: bone structure, balance, and remodeling before and 3 years after surgical treatment.
Steiniche T; Christiansen P; Vesterby A; Ullerup R; Hessov I; Mosekilde LE; Melsen F
Bone; 2000 May; 26(5):535-43. PubMed ID: 10773596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
